High prevalence of kidney failure due to unhealthy lifestyles has led to increased demand for kidney function tests. According to the World Health Organization (WHO), there is nearly 8% rise in the chronic kidney disease (CKD) cases every year. Kidney function tests can determine the probability of CKD in diabetic and non-diabetics at early stages.
How it Works?
Kidney or renal function tests can determine the possibility of CKD and other kidney-related disorders. Different types of tests such as creatinine clearance test, furosemide test, and glomerular filtration rate (GFR or eGFR) test are used to determine functioning of renal system. Early detection of kidney failure can prevent the progression of such diseases. Hypertension, frequent urge to urinate, and swelling of hands & feet are the common symptoms of kidney diseases.
Recently, the United States Food & Drug Administration (FDA) approved marketing of a noninvasive kidney function test. . EUROIMMUN US, Inc., a US-based company has developed this test for membranous glomerulonephritis (MGN) diagnosis. MGN affects the glomeruli in the kidney.
Proteomics International Limted, an Australian life sciences company, launched a prognostic test to determine the possibility of diabetic kidney disease (DKD). This blood sample test identifies at-risk groups and recommends treatment options to prevent prognosis of the disease.
The worldwide kidney function tests market is projected at nearly USD 2 billion by 2025, according to Grand View Research, Inc. It is anticipated to grow at a 5.2% CAGR over the forecast period (2014 to 2025). High prevalence of kidney disorders is the key driving factor.
Dilution & concentration, imaging, clearance, and urine tests are the major products within the market. Clearance tests gained over 30% market share in 2016. Imaging tests on the other hand, may register a high CAGR over the forthcoming years.
Hospitals dominated the end-user segment in 2016 on account of sophisticated infrastructure and huge patient volume. Diagnostic laboratories are expected to exhibit a lucrative CAGR during the forecast period. Prominent market players include Quest Diagnostics, Merck Millipore, Randox Laboratories, and Siemens Healthineers.
In-Depth Research Report On Kidney Function Tests Market: